Discover 1,881 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,881
Active & Responsive
Mechanisms of Behavioral Activation (BA)
for
Depression
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 15 - 17
Code: NCT05548244
Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
for
Alzheimer Disease, Physical Activity
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 65+
Code: NCT06496425
Recruiting
Active & Responsive
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
for
Solid Tumor
Location: Pittsburgh PA, Atlanta GA, St Louis MO, Houston TX
Sponsor: Emory University
Sex: All
Age: 1 - 30
Code: NCT04469530
Phase2, Recruiting
Active & Responsive
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Effects of Treadmill Training and Whole-body Vibration in Children With Cerebral Palsy
for
Cerebral Palsy
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 6 - 17
Code: NCT04630392
Recruiting
Active & Responsive
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
for
Neisseria Meningitidis
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 25
Code: NCT07197762
Recruiting
Active & Responsive
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
for
Chronic Cough (CC), Refractory Chronic Cough,
Location: Atlanta GA, Missoula MT
Sponsor: University of Montana
Sex: All
Age: 18 - 70+
Code: NCT06960759
Phase2, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
for
ADHD
Location: Worcester MA, Springfield MA, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 6 - 11
Code: NCT07717879
Phase3, Recruiting
Active & Responsive
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
for
Coronary Artery Disease Risk Factors Multiple,
Location: New York NY, Durham NC, Hiram GA, Birmingham AL,
Sponsor: Duke University
Sex: All
Age: 30 - 60
Code: NCT07232069
Phase3, Recruiting
Active & Responsive
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
for
Stomatitis
Location: Wynnewood PA, East Syracuse NY, Wilson NC, Athens GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07357597
Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
for
Adults With Overweight/Obesity and Type 2 Diabetes
Location: Hollywood FL, Savannah GA, Tampa FL, Decatur GA,
Sponsor: Antag Therapeutics
Sex: All
Age: 18+
Code: NCT07724340
Phase2, Recruiting
Active & Responsive
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Atlanta GA, Peoria IL, Los Angeles CA
Sponsor: CatalYm GmbH
Sex: All
Age: 18 - 70+
Code: NCT07219459
Phase2, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Winston-Salem NC,